FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RANIBIZUMAB
异名/同义词BYOOVIZ
CIMERLI
FAB-12 VARIANT Y0317
FYB201
FYB-201
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL RHUFAB V2 1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUFAB V2 LIGHT CHAIN
PF582
PF-582
PF-582 (RANIBIZUMAB BIOSIMILAR)
RANIBIZUMAB
RANIBIZUMAB [EMA EPAR]
RANIBIZUMAB [INN]
RANIBIZUMAB [JAN]
RANIBIZUMAB [MART.]
RANIBIZUMAB [MI]
RANIBIZUMAB [PURPLE BOOK CDER]
RANIBIZUMAB [USAN]
RANIBIZUMAB [VANDF]
RANIBIZUMAB NUNA [WHO-DD]
RANIBIZUMAB-EQRN
RANIBIZUMAB-NUNA
RBZ
RANIBIZUMAB [WHO-DD]
RANIBIZUMAB BIOSIMILAR PF582
RG-3645
RHUFAB
SUSVIMO
CAS登记号347396-82-1
物质唯一标识(Unique Ingredient Identifier)ZL1R02VT79
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System